The Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy brand, founded in 2006 (France), from 2757 sister brands and 17477 competing brands. Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy is a brand of SANOFI, listed on the stock exchange of Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. The sector of Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy is Drug Manufacturers.

Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy is a brand of SANOFI (SAN) Sustainability

Here is the evolution of interest in SANOFI "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability: Result of Google's query: "Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy sustainability"
: Sustainability -> Share price